Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook

Gilead Sciences, Inc. (GILD) reported better-than-expected third-quarter results and raised its annual earnings guidance.Adjusted earnings per share (EPS) of $2.02 beat the Zacks Consensus Estimate of$1.58. In the year-ago quarter, the company reported adjusted earnings of 2.29 per share.The year-over-year decrease was due to higher acquired IPR&D and tax expenses.Total revenues of 7.5 billion beat the Zacks Consensus Estimate of $7 billion. Revenues also increased 7% year over year, primarily due to hig ...